首页> 外文期刊>Chest: The Journal of Circulation, Respiration and Related Systems >Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?
【24h】

Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?

机译:小儿非囊性纤维化支气管扩张的纵向生长和肺功能:什么影响肺功能稳定性?

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Longitudinal FEV(1) data in children with non-cystic fibrosis (non-CF) bronchiectasis (BE) are contradictory, and there are no multifactor data on the evolution of lung function and growth in this group. We longitudinally reviewed lung function and growth in children with non-CF BE and explored biologically plausible factors associated with changes in these parameters over time. METHODS: Fifty-two children with > or = 3 years of lung function data were retrospectively reviewed. Changes in annual anthropometry and spirometry at year 3 and year 5 from baseline were analyzed. The impact of sex, age, cause, baseline FEV(1), exacerbation frequency, radiologic extent, socioeconomic status, environmental tobacco smoke exposure, and period of diagnosis was evaluated. RESULTS: Over 3 years, the group mean forced expiratory flow midexpiratory phase percent predicted and BMI z-score improved by 3.01 (P = .04; 95% CI, 0.14-5.86) and 0.089 (P = .01; 95% CI, 0.02-0.15) per annum, respectively. FEV(1)% predicted, FVC% predicted, and height z-score all showed nonsignificant improvement. Over 5 years, there was improvement in FVC% predicted (slope 1.74; P = .001) annually, but only minor improvement in other parameters. Children with immunodeficiency and those with low baseline FEV(1) had significantly lower BMI at diagnosis. Frequency of hospitalized exacerbation and low baseline FEV(1) were the only significant predictors of change in FEV(1) over 3 years. Decline in FEV(1)% predicted was large (but nonsignificant) for each additional year in age of diagnosis. CONCLUSIONS: Spirometric and anthropometric parameters in children with non-CF BE remain stable over a 3- to 5-year follow-up period once appropriate therapy is instituted. Severe exacerbations result in accelerated lung function decline. Increased medical cognizance of children with chronic moist cough is needed for early diagnosis, better management, and improving overall outcome in BE.
机译:背景:非囊性纤维化(non-CF)支气管扩张(BE)儿童的纵向FEV(1)数据相互矛盾,并且该组中没有关于肺功能演变和生长的多因素数据。我们纵向审查了非CF BE儿童的肺功能和生长情况,并探讨了与这些参数随时间变化相关的生物学上合理的因素。方法:回顾性分析52例肺功能数据≥3年的儿童。分析了从基线开始的第3年和第5年的年度人体测量和肺活量测量的变化。评估了性别,年龄,病因,基线FEV(1),病情加重频率,放射学范围,社会经济状况,环境烟尘暴露和诊断时间的影响。结果:在3年多的时间里,该组的平均预期平均呼气强度,呼气中期百分比和BMI z评分分别提高了3.01(P = .04; 95%CI,0.14-5.86)和0.089(P = .01; 95%CI,每年0.02-0.15)。预测的FEV(1)%,预测的FVC%和高度z得分均无明显改善。在过去的5年中,预测的FVC%每年都有改善(斜率1.74; P = .001),但其他参数仅略有改善。免疫缺陷儿童和基线FEV(1)低的儿童在诊断时的BMI明显降低。住院恶化的频率和低基线FEV(1)是3年内FEV(1)变化的唯一重要预测指标。诊断年龄每增加一年,预测的FEV(1)%下降幅度很大(但不显着)。结论:一旦采取适当的治疗措施,非CF BE儿童的肺活量和人体测量参数在3至5年的随访期内保持稳定。严重加重导致加速的肺功能下降。早期湿润咳嗽儿童需要提高医学认知度,才能早期诊断,改善治疗并改善BE的总体预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号